Overview
Seiichi Tamai practices practicing medicine in Tokorozawa, Japan.
His clinical expertise encompasses Gallbladder Adenocarcinoma, Glomerulonephritis, and Testicular Cancer.
He is actively involved in clinical research, co-authoring 18 peer reviewed articles.
Gender
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Seiichi Tamai
Is Seiichi Tamai a top-rated expert for Gallbladder Adenocarcinoma?
MediFind is an objective health platform that identifies experts based on real-world data. Seiichi Tamai is classified as an Experienced expert for Gallbladder Adenocarcinoma, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Seiichi Tamai participate in research or clinical trials?
Yes. Seiichi Tamai has published 18 articles and abstracts on conditions like Gallbladder Adenocarcinoma. You can view a list of Seiichi Tamai's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Gallbladder AdenocarcinomaMr. Tamai isExperienced. Learn about Gallbladder Adenocarcinoma.
- GlomerulonephritisMr. Tamai isExperienced. Learn about Glomerulonephritis.
- Testicular CancerMr. Tamai isExperienced. Learn about Testicular Cancer.